← Browse by Condition
Medical Condition

early small ct1n0 triple negative breast cancer

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2
NCT05215106 Phase 2
Recruiting

Short-term Pre-OPerative Durvalumab (MEDI 4736) in Early Small Triple Negative Breast Cancer Patients (POP-Durva)

Enrollment
200 pts
Location
France
Sponsor
Gustave Roussy, Cancer Campus,...
View Trial →